<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05100264</url>
  </required_header>
  <id_info>
    <org_study_id>68/7/22-9-21</org_study_id>
    <nct_id>NCT05100264</nct_id>
  </id_info>
  <brief_title>Effect of Acidic Vaginal pH on the Efficacy of Dinoprostone for Labor Induction</brief_title>
  <official_title>Effect of Acidic Vaginal pH on the Efficacy of Dinoprostone (PGE2) Vaginal Tablet for Labor Induction in Full Term Pregnant Women: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandra Hospital, Athens, Greece</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National and Kapodistrian University of Athens</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Alexandra Hospital, Athens, Greece</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acidification of vaginal pH has been proposed as a potential factor that could help increase&#xD;
      the efficacy of vaginal prostaglandins in labor induction. The aim of the present randomized&#xD;
      controlled trial is to evaluate the impact of an acidic vaginal pH on the progress of labor&#xD;
      induction with dinoprostone (PGE2) vaginal tablet.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 25, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Randomization will be computer generated. Allocation concealment will be ensured by opaque sealed envelopes. Blinding of outcomes assessor, principal as well as other investigators will be ensured as randomization will be performed by an external investigator that will not participate in the clinical process of the study or the statistical analysis. The ward midwife will open the randomization envelope after patient enrollment and different types of vaginal washing will be applied as per randomization. Participant as well outcomes assessor (physician that will evaluate the progress of labor as well statistician involved in the analysis) will be blinded to the procedure.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Interval from induction to delivery</measure>
    <time_frame>36 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interval from induction to active labor</measure>
    <time_frame>36 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interval from induction to second stage of labor</measure>
    <time_frame>36 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Failure of induction</measure>
    <time_frame>36 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Labor, Induced</condition>
  <condition>Induced; Birth</condition>
  <arm_group>
    <arm_group_label>Vaginal washing 5% acetic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Vaginal washing 0.9% N/S</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vaginal washing with 5% acetic acid</intervention_name>
    <description>Induction of labor (vaginal tablet dinoprostone and vaginal washing with 5% acetic acid)</description>
    <arm_group_label>Vaginal washing 5% acetic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vaginal washing with 0.9% NS</intervention_name>
    <description>Induction of labor (vaginal tablet dinoprostone and vaginal washing 0.9% NS)</description>
    <arm_group_label>Vaginal washing 0.9% N/S</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria&#xD;
&#xD;
          -  Singleton pregnancy&#xD;
&#xD;
          -  Full term (&gt;37 weeks)&#xD;
&#xD;
          -  Cephalic presentation&#xD;
&#xD;
          -  Reactive NST&#xD;
&#xD;
          -  Absence of spontaneous uterine contractions&#xD;
&#xD;
          -  No contraindications to vaginal delivery&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  Multifetal pregnancy&#xD;
&#xD;
          -  Fetal malpresentation&#xD;
&#xD;
          -  Preterm delivery (&lt;37 weeks)&#xD;
&#xD;
          -  Advanced maternal age (&gt;40 years)&#xD;
&#xD;
          -  Bishop score &gt; 7&#xD;
&#xD;
          -  Fetal macrosomia ( &gt;4500 gr)&#xD;
&#xD;
          -  Non reassuring NST&#xD;
&#xD;
          -  Suspected chorioamnionitis&#xD;
&#xD;
          -  Previous cesarean delivery or other uterine surgery&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georgios Daskalakis</last_name>
    <role>Study Director</role>
    <affiliation>Alexandra General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michail Panagiotopoulos</last_name>
    <phone>+306973160031</phone>
    <email>michpanag@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Georgios Daskalakis</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Alexandra General Hospital</name>
      <address>
        <city>Athens</city>
        <zip>11528</zip>
        <country>Greece</country>
      </address>
    </facility>
    <contact>
      <last_name>Michail Panagiotopoulos, MD, MSc</last_name>
    </contact>
    <contact_backup>
      <last_name>Georgios Daskalakis, Professor</last_name>
    </contact_backup>
    <investigator>
      <last_name>Michail Panagiotopoulos</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vasilios Pergialiotis</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marianna Theodora</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Panagiotis Antsaklis</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michail Sindos</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pelopidas Koutroumanis</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 18, 2021</study_first_submitted>
  <study_first_submitted_qc>October 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alexandra Hospital, Athens, Greece</investigator_affiliation>
    <investigator_full_name>Georgios Daskalakis</investigator_full_name>
    <investigator_title>Professor of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>labor induction</keyword>
  <keyword>dinoprostone</keyword>
  <keyword>vaginal pH</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetic Acid</mesh_term>
    <mesh_term>Retinol acetate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

